Capital/Financing Update • Sep 6, 2017
Capital/Financing Update
Open in ViewerOpens in native device viewer
| Clear growth strategy |
Strong and attractive acquisition pipeline |
||||
|---|---|---|---|---|---|
| Financing | |||||
| Instrument | Status Quo | ||||
| Equity (capital increase) | • Increase in the number of shares in 2016 by 68% (CHORUS takeover & small capital increase) • Flexible strategic option for inorganic growth • Dilutive and eligible for dividends |
+ / - | |||
| Debt Capital | ▪ Attractive financing conditions ▪ Debt financing weights on equity ratio and increases overall leverage |
+ / - | |||
| ▪ (IFRS) Mezzanine Capital ▪ No dilutive effects (in the first 6 years) ▪ Utilise on current positive 'market window' |
Hybrid structure can be accounted for as equity | ++ |
Debt financing would have weighted on the equity ratio and eventually led to an equity ratio below target
▪ Berenberg and Morgan Stanley acted as Joint Bookrunners
| Terms | Perpetual/Non-Call 6 | |
|---|---|---|
| Size | 97.3 | |
| Status | Perpetual Subordinated Convertible Bond |
|
| Maturity / First Call |
Perpetual / Non-call 6 |
|
| Issuer Soft Call |
130% trigger after 4 years |
|
| Issue price (%) |
100.0 | |
| Dividend Protection threshold |
EUR 0.10 | |
| Coupon after First Call Date (payable semi annualy) |
5.25% | |
| Coupon after First Call date | 5yr mid swap rate + [11%] (reset every 5 yrs) |
|
| Conversion premium |
25.0% | |
| Conversion price (EUR) |
7.59 | |
| #underlying shares |
12.8m | |
| % of total outstanding shares |
10.0% |
* Assuming a reference share price of EUR 6.0754; maximum of what was possible given legal constraints 5
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.